Daily Oncology News

The ESMO OncologyPRO news, provided in partnership with medwireNews, ensures that you're always kept up to date with the latest developments in the field of medical oncology. You can browse articles by date or by topic.

Did you know how medwireNews writes our articles?


Date Title Topic
03 Jul 2017 Preventive Tamoxifen Side Effects May Be Partly Explained by Menopausal Symptoms Anti-Cancer Agents & Biologic Therapy - Breast Cancer - Cancer Aetiology, Epidemiology, Prevention - Complications of Treatment
30 Jun 2017 PD-1 Inhibitor Therapy Efficacy May Be ‘Limited’ In Soft-Tissue Sarcoma, GIST Cancer Immunology and Immunotherapy - Soft Tissue Sarcomas - GIST - Translational Research
29 Jun 2017 Nivolumab Preserves QoL For Advanced Head & Neck SCC Patients Cancer Immunology and Immunotherapy - Head and Neck Cancers
28 Jun 2017 Patient Preference Supports Subcutaneous Trastuzumab For Metastatic HER2-Positive Breast Cancer Anti-Cancer Agents & Biologic Therapy - Breast Cancer
27 Jun 2017 First-Line Evofosfamide Plus Doxorubicin Fails To Improve Advanced Soft-Tissue Sarcoma OS Anti-Cancer Agents & Biologic Therapy - Soft Tissue Sarcomas
26 Jun 2017 MRI Improves Detection After Breast-Conserving Therapy In Young Breast Cancer Patients Breast Cancer, Early Stage - Imaging, Diagnosis and Staging
23 Jun 2017 Taxane Switch Boosts PSA Reduction Success For Metastatic CRPC Anti-Cancer Agents & Biologic Therapy - Prostate Cancer
22 Jun 2017 CONVERT Fails To Show Once Daily Chemoradiotherapy Regimen Superiority For Limited-Stage SCLC Surgery and/or Radiotherapy of Cancer
21 Jun 2017 OS Equal For Cetuximab And Bevacizumab In Advanced KRAS Wild-Type CRC Anti-Cancer Agents & Biologic Therapy - Colon Cancer - Rectal Cancer
20 Jun 2017 12-Month OS Best Current Predictor Of Metastatic NSCLC Trial OS Endpoint Anti-Cancer Agents & Biologic Therapy - Cancer Immunology and Immunotherapy - Non-Small-Cell Lung Cancer, Metastatic
19 Jun 2017 Lenvatinib Effective For Radioiodine-Refractory Differentiated Thyroid Cancer Patients Of All Ages Anti-Cancer Agents & Biologic Therapy - Thyroid Cancer
16 Jun 2017 Small Bowel Adenocarcinoma Shows ‘Unique’, Targetable Genomic Profile Gastrointestinal Cancers - Pathology/Molecular Biology
15 Jun 2017 Brentuximab Vedotin ‘Potentially Practice Changing’ For Cutaneous T-Cell Lymphoma Anti-Cancer Agents & Biologic Therapy - Haematologic Malignancies - Lymphomas
14 Jun 2017 Second-Line Ceritinib Best For ALK-rearranged NSCLC After Crizotinib Anti-Cancer Agents & Biologic Therapy - Non-Small-Cell Lung Cancer, Metastatic - Personalised Medicine
13 Jun 2017 ASCO 2017: KEYNOTE-045, -052 Support Pembrolizumab For Advanced Urothelial Cancer Populations Cancer Immunology and Immunotherapy - Urothelial Cancers